Regulation of amyloid-β production by the prion protein

References

• Burns A, Iliffe S. Alzheimer’s disease. BMJ 2009; 338:b158; http://dx.doi.org/10.1136/bmj.b158; PMID: 19196745
   PubMed Web of Science ®Google Scholar
• Mount C, Downton C. Alzheimer disease: progress or profit?. Nat Med 2006; 12:780 - 4; http://dx.doi.org/10.1038/nm0706-780; PMID: 16829947
   PubMed Web of Science ®Google Scholar
• Morrissette DA, Parachikova A, Green KN, LaFerla FM. Relevance of transgenic mouse models to human Alzheimer disease. J Biol Chem 2009; 284:6033 - 7; http://dx.doi.org/10.1074/jbc.R800030200; PMID: 18948253
   PubMed Web of Science ®Google Scholar
• Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 1987; 76:465 - 79; http://dx.doi.org/10.1111/j.1600-0447.1987.tb02906.x; PMID: 3324647
   PubMed Web of Science ®Google Scholar
• Vardy ER, Catto AJ, Hooper NM. Proteolytic mechanisms in amyloid-beta metabolism: therapeutic implications for Alzheimer’s disease. Trends Mol Med 2005; 11:464 - 72; http://dx.doi.org/10.1016/j.molmed.2005.08.004; PMID: 16153892
   PubMed Web of Science ®Google Scholar
• Nunan J, Small DH. Regulation of APP cleavage by alpha-, beta- and gamma-secretases. FEBS Lett 2000; 483:6 - 10; http://dx.doi.org/10.1016/S0014-5793(00)02076-7; PMID: 11033346
   PubMed Web of Science ®Google Scholar
• Pimplikar SW. Reassessing the amyloid cascade hypothesis of Alzheimer’s disease. Int J Biochem Cell Biol 2009; 41:1261 - 8; http://dx.doi.org/10.1016/j.biocel.2008.12.015; PMID: 19124085
   PubMed Web of Science ®Google Scholar
• Fukumoto H, Cheung BS, Hyman BT, Irizarry MC. Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol 2002; 59:1381 - 9; http://dx.doi.org/10.1001/archneur.59.9.1381; PMID: 12223024
   PubMed Web of Science ®Google Scholar
• Li R, Lindholm K, Yang LB, Yue X, Citron M, Yan R, et al. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer’s disease patients. Proc Natl Acad Sci U S A 2004; 101:3632 - 7; http://dx.doi.org/10.1073/pnas.0205689101; PMID: 14978286
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Sigurdson C, Heikenwaelder M. Molecular mechanisms of prion pathogenesis. Annu Rev Pathol 2008; 3:11 - 40; http://dx.doi.org/10.1146/annurev.pathmechdis.3.121806.154326; PMID: 18233951
   PubMed Web of Science ®Google Scholar
• Hainfellner JA, Wanschitz J, Jellinger K, Liberski PP, Gullotta F, Budka H. Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease. Acta Neuropathol 1998; 96:116 - 22; http://dx.doi.org/10.1007/s004010050870; PMID: 9705125
   PubMed Web of Science ®Google Scholar
• Voigtländer T, Klöppel S, Birner P, Jarius C, Flicker H, Verghese-Nikolakaki S, et al. Marked increase of neuronal prion protein immunoreactivity in Alzheimer’s disease and human prion diseases. Acta Neuropathol 2001; 101:417 - 23; PMID: 11484812
   PubMed Web of Science ®Google Scholar
• Del Bo R, Scarlato M, Ghezzi S, Martinelli-Boneschi F, Fenoglio C, Galimberti G, et al. Is M129V of PRNP gene associated with Alzheimer’s disease? A case-control study and a meta-analysis. Neurobiol Aging 2006; 27:770 - , e1-770, e5; http://dx.doi.org/10.1016/j.neurobiolaging.2005.05.025; PMID: 16099550
   PubMed Web of Science ®Google Scholar
• Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 2007; 39:17 - 23; http://dx.doi.org/10.1038/ng1934; PMID: 17192785
   PubMed Web of Science ®Google Scholar
• Dermaut B, Croes EA, Rademakers R, Van den Broeck M, Cruts M, Hofman A, et al. PRNP Val129 homozygosity increases risk for early-onset Alzheimer’s disease. Ann Neurol 2003; 53:409 - 12; http://dx.doi.org/10.1002/ana.10507; PMID: 12601712
   PubMed Web of Science ®Google Scholar
• Riemenschneider M, Klopp N, Xiang W, Wagenpfeil S, Vollmert C, Müller U, et al. Prion protein codon 129 polymorphism and risk of Alzheimer disease. Neurology 2004; 63:364 - 6; PMID: 15277640
   PubMed Web of Science ®Google Scholar
• Parkin ET, Watt NT, Hussain I, Eckman EA, Eckman CB, Manson JC, et al. Cellular prion protein regulates beta-secretase cleavage of the Alzheimer’s amyloid precursor protein. Proc Natl Acad Sci U S A 2007; 104:11062 - 7; http://dx.doi.org/10.1073/pnas.0609621104; PMID: 17573534
   PubMed Web of Science ®Google Scholar
• Hooper NM, Turner AJ. A new take on prions: preventing Alzheimer’s disease. Trends Biochem Sci 2008; 33:151 - 5; http://dx.doi.org/10.1016/j.tibs.2008.01.004; PMID: 18343669
   PubMed Web of Science ®Google Scholar
• Andersen OM, Reiche J, Schmidt V, Gotthardt M, Spoelgen R, Behlke J, et al. Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc Natl Acad Sci U S A 2005; 102:13461 - 6; http://dx.doi.org/10.1073/pnas.0503689102; PMID: 16174740
   PubMed Web of Science ®Google Scholar
• Spoelgen R, von Arnim CA, Thomas AV, Peltan ID, Koker M, Deng A, et al. Interaction of the cytosolic domains of sorLA/LR11 with the amyloid precursor protein (APP) and beta-secretase beta-site APP-cleaving enzyme. J Neurosci 2006; 26:418 - 28; http://dx.doi.org/10.1523/JNEUROSCI.3882-05.2006; PMID: 16407538
   PubMed Web of Science ®Google Scholar
• Sannerud R, Declerck I, Peric A, Raemaekers T, Menendez G, Zhou L, et al. ADP ribosylation factor 6 (ARF6) controls amyloid precursor protein (APP) processing by mediating the endosomal sorting of BACE1. Proc Natl Acad Sci U S A 2011; 108:E559 - 68; http://dx.doi.org/10.1073/pnas.1100745108; PMID: 21825135
   PubMedGoogle Scholar
• He X, Li F, Chang WP, Tang J. GGA proteins mediate the recycling pathway of memapsin 2 (BACE). J Biol Chem 2005; 280:11696 - 703; http://dx.doi.org/10.1074/jbc.M411296200; PMID: 15615712
   PubMed Web of Science ®Google Scholar
• Wahle T, Thal DR, Sastre M, Rentmeister A, Bogdanovic N, Famulok M, et al. GGA1 is expressed in the human brain and affects the generation of amyloid beta-peptide. J Neurosci 2006; 26:12838 - 46; http://dx.doi.org/10.1523/JNEUROSCI.1982-06.2006; PMID: 17151287
   PubMed Web of Science ®Google Scholar
• Griffiths HH, Whitehouse IJ, Baybutt H, Brown D, Kellett KA, Jackson CD, et al. Prion protein interacts with BACE1 protein and differentially regulates its activity toward wild type and Swedish mutant amyloid precursor protein. J Biol Chem 2011; 286:33489 - 500; http://dx.doi.org/10.1074/jbc.M111.278556; PMID: 21795680
   PubMed Web of Science ®Google Scholar
• Haass C, Lemere CA, Capell A, Citron M, Seubert P, Schenk D, et al. The Swedish mutation causes early-onset Alzheimer’s disease by beta-secretase cleavage within the secretory pathway. Nat Med 1995; 1:1291 - 6; http://dx.doi.org/10.1038/nm1295-1291; PMID: 7489411
   PubMed Web of Science ®Google Scholar
• Koo EH, Squazzo SL. Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J Biol Chem 1994; 269:17386 - 9; PMID: 8021238
   PubMed Web of Science ®Google Scholar
• Benjannet S, Elagoz A, Wickham L, Mamarbachi M, Munzer JS, Basak A, et al. Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production. J Biol Chem 2001; 276:10879 - 87; http://dx.doi.org/10.1074/jbc.M009899200; PMID: 11152688
   PubMed Web of Science ®Google Scholar
• Creemers JW, Ines Dominguez D, Plets E, Serneels L, Taylor NA, Multhaup G, et al. Processing of beta-secretase by furin and other members of the proprotein convertase family. J Biol Chem 2001; 276:4211 - 7; http://dx.doi.org/10.1074/jbc.M006947200; PMID: 11071887
   PubMed Web of Science ®Google Scholar
• Capell A, Steiner H, Willem M, Kaiser H, Meyer C, Walter J, et al. Maturation and pro-peptide cleavage of beta-secretase. J Biol Chem 2000; 275:30849 - 54; http://dx.doi.org/10.1074/jbc.M003202200; PMID: 10801872
   PubMed Web of Science ®Google Scholar
• Huse JT, Pijak DS, Leslie GJ, Lee VM, Doms RW. Maturation and endosomal targeting of beta-site amyloid precursor protein-cleaving enzyme. The Alzheimer’s disease beta-secretase. J Biol Chem 2000; 275:33729 - 37; http://dx.doi.org/10.1074/jbc.M004175200; PMID: 10924510
   PubMed Web of Science ®Google Scholar
• Hébert SS, Bourdages V, Godin C, Ferland M, Carreau M, Lévesque G. Presenilin-1 interacts directly with the beta-site amyloid protein precursor cleaving enzyme (BACE1). Neurobiol Dis 2003; 13:238 - 45; http://dx.doi.org/10.1016/S0969-9961(03)00035-4; PMID: 12901838
   PubMed Web of Science ®Google Scholar
• Scherzer CR, Offe K, Gearing M, Rees HD, Fang G, Heilman CJ, et al. Loss of apolipoprotein E receptor LR11 in Alzheimer disease. Arch Neurol 2004; 61:1200 - 5; http://dx.doi.org/10.1001/archneur.61.8.1200; PMID: 15313836
   PubMed Web of Science ®Google Scholar
• Eggert S, Paliga K, Soba P, Evin G, Masters CL, Weidemann A, et al. The proteolytic processing of the amyloid precursor protein gene family members APLP-1 and APLP-2 involves alpha-, beta-, gamma-, and epsilon-like cleavages: modulation of APLP-1 processing by n-glycosylation. J Biol Chem 2004; 279:18146 - 56; http://dx.doi.org/10.1074/jbc.M311601200; PMID: 14970212
   PubMed Web of Science ®Google Scholar
• Li Q, Südhof TC. Cleavage of amyloid-beta precursor protein and amyloid-beta precursor-like protein by BACE 1. J Biol Chem 2004; 279:10542 - 50; http://dx.doi.org/10.1074/jbc.M310001200; PMID: 14699153
   PubMed Web of Science ®Google Scholar
• Kitazume S, Tachida Y, Oka R, Shirotani K, Saido TC, Hashimoto Y. Alzheimer’s beta-secretase, beta-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase. Proc Natl Acad Sci USA 2001; 98:13554 - 9; http://dx.doi.org/10.1073/pnas.241509198; PMID: 11698669
   PubMed Web of Science ®Google Scholar
• von Arnim CA, Kinoshita A, Peltan ID, Tangredi MM, Herl L, Lee BM, et al. The low density lipoprotein receptor-related protein (LRP) is a novel beta-secretase (BACE1) substrate. J Biol Chem 2005; 280:17777 - 85; http://dx.doi.org/10.1074/jbc.M414248200; PMID: 15749709
   PubMed Web of Science ®Google Scholar
• Griffiths HH, Morten IJ, Hooper NM. Emerging and potential therapies for Alzheimer’s disease. Expert Opin Ther Targets 2008; 12:693 - 704; http://dx.doi.org/10.1517/14728222.12.6.693; PMID: 18479216
   PubMed Web of Science ®Google Scholar
• Postina R, Schroeder A, Dewachter I, Bohl J, Schmitt U, Kojro E, et al. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J Clin Invest 2004; 113:1456 - 64; PMID: 15146243
   PubMed Web of Science ®Google Scholar
• Altmeppen HC, Prox J, Puig B, Kluth MA, Bernreuther C, Thurm D, et al. Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo. Mol Neurodegener 2011; 6:36; http://dx.doi.org/10.1186/1750-1326-6-36; PMID: 21619641
   PubMed Web of Science ®Google Scholar
• Jorissen E, Prox J, Bernreuther C, Weber S, Schwanbeck R, Serneels L, et al. The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex. J Neurosci 2010; 30:4833 - 44; http://dx.doi.org/10.1523/JNEUROSCI.5221-09.2010; PMID: 20371803
   PubMed Web of Science ®Google Scholar
• Taylor DR, Parkin ET, Cocklin SL, Ault JR, Ashcroft AE, Turner AJ, et al. Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein. J Biol Chem 2009; 284:22590 - 600; http://dx.doi.org/10.1074/jbc.M109.032599; PMID: 19564338
   PubMed Web of Science ®Google Scholar
• Cissé MA, Sunyach C, Lefranc-Jullien S, Postina R, Vincent B, Checler F. The disintegrin ADAM9 indirectly contributes to the physiological processing of cellular prion by modulating ADAM10 activity. J Biol Chem 2005; 280:40624 - 31; http://dx.doi.org/10.1074/jbc.M506069200; PMID: 16236709
   PubMed Web of Science ®Google Scholar
• Vincent B, Paitel E, Frobert Y, Lehmann S, Grassi J, Checler F. Phorbol ester-regulated cleavage of normal prion protein in HEK293 human cells and murine neurons. J Biol Chem 2000; 275:35612 - 6; http://dx.doi.org/10.1074/jbc.M004628200; PMID: 10952979
   PubMed Web of Science ®Google Scholar
• Vincent B, Paitel E, Saftig P, Frobert Y, Hartmann D, De Strooper B, et al. The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem 2001; 276:37743 - 6; PMID: 11477090
   PubMed Web of Science ®Google Scholar
• Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, et al. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 2000; 20:4050 - 8; PMID: 10818140
   PubMed Web of Science ®Google Scholar
• Calella AM, Farinelli M, Nuvolone M, Mirante O, Moos R, Falsig J, et al. Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol Med 2010; 2:306 - 14; http://dx.doi.org/10.1002/emmm.201000082; PMID: 20665634
   PubMed Web of Science ®Google Scholar
• Gimbel DA, Nygaard HB, Coffey EE, Gunther EC, Laurén J, Gimbel ZA, et al. Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci 2010; 30:6367 - 74; http://dx.doi.org/10.1523/JNEUROSCI.0395-10.2010; PMID: 20445063
   PubMed Web of Science ®Google Scholar
• Schwarze-Eicker K, Keyvani K, Görtz N, Westaway D, Sachser N, Paulus W. Prion protein (PrPc) promotes beta-amyloid plaque formation. Neurobiol Aging 2005; 26:1177 - 82; http://dx.doi.org/10.1016/j.neurobiolaging.2004.10.004; PMID: 15917101
   PubMed Web of Science ®Google Scholar
• Cissé M, Sanchez PE, Kim DH, Ho K, Yu GQ, Mucke L. Ablation of cellular prion protein does not ameliorate abnormal neural network activity or cognitive dysfunction in the J20 line of human amyloid precursor protein transgenic mice. J Neurosci 2011; 31:10427 - 31; http://dx.doi.org/10.1523/JNEUROSCI.1459-11.2011; PMID: 21775587
   PubMed Web of Science ®Google Scholar
• Thinakaran G, Teplow DB, Siman R, Greenberg B, Sisodia SS. Metabolism of the “Swedish” amyloid precursor protein variant in neuro2a (N2a) cells. Evidence that cleavage at the “beta-secretase” site occurs in the golgi apparatus. J Biol Chem 1996; 271:9390 - 7; PMID: 8621605
   PubMed Web of Science ®Google Scholar
• Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, et al. Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999; 286:735 - 41; http://dx.doi.org/10.1126/science.286.5440.735; PMID: 10531052
   PubMed Web of Science ®Google Scholar
• Yan R, Han P, Miao H, Greengard P, Xu H. The transmembrane domain of the Alzheimer’s beta-secretase (BACE1) determines its late Golgi localization and access to beta -amyloid precursor protein (APP) substrate. J Biol Chem 2001; 276:36788 - 96; http://dx.doi.org/10.1074/jbc.M104350200; PMID: 11466313
   PubMed Web of Science ®Google Scholar
• Duyckaerts C, Potier MC, Delatour B. Alzheimer disease models and human neuropathology: similarities and differences. Acta Neuropathol 2008; 115:5 - 38; http://dx.doi.org/10.1007/s00401-007-0312-8; PMID: 18038275
   PubMed Web of Science ®Google Scholar
• Kokjohn TA, Roher AE. Amyloid precursor protein transgenic mouse models and Alzheimer’s disease: understanding the paradigms, limitations, and contributions. Alzheimers Dement 2009; 5:340 - 7; http://dx.doi.org/10.1016/j.jalz.2009.03.002; PMID: 19560104
   PubMed Web of Science ®Google Scholar
• Schieb H, Kratzin H, Jahn O, Möbius W, Rabe S, Staufenbiel M, et al. Beta-amyloid peptide variants in brains and cerebrospinal fluid from amyloid precursor protein (APP) transgenic mice: comparison with human Alzheimer amyloid. J Biol Chem 2011; 286:33747 - 58; http://dx.doi.org/10.1074/jbc.M111.246561; PMID: 21795681
   PubMed Web of Science ®Google Scholar
• Rezaie P, Pontikis CC, Hudson L, Cairns NJ, Lantos PL. Expression of cellular prion protein in the frontal and occipital lobe in Alzheimer’s disease, diffuse Lewy body disease, and in normal brain: an immunohistochemical study. J Histochem Cytochem 2005; 53:929 - 40; http://dx.doi.org/10.1369/jhc.4A6551.2005; PMID: 16055747
   PubMed Web of Science ®Google Scholar
• Meyne F, Gloeckner SF, Ciesielczyk B, Heinemann U, Krasnianski A, Meissner B, et al. Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders. J Alzheimers Dis 2009; 17:863 - 73; PMID: 19542614
   PubMed Web of Science ®Google Scholar
• Velayos JL, Irujo A, Cuadrado-Tejedor M, Paternain B, Moleres FJ, Ferrer V. The cellular prion protein and its role in Alzheimer disease. Prion 2009; 3:110 - 7; http://dx.doi.org/10.4161/pri.3.2.9135; PMID: 19556894
   PubMed Web of Science ®Google Scholar
• Whitehouse IJ, Jackson C, Turner AJ, Hooper NM. Prion protein is reduced in aging and in sporadic but not in familial Alzheimer’s disease. J Alzheimers Dis 2010; 22:1023 - 31; PMID: 20930299
   PubMed Web of Science ®Google Scholar
• Saijo E, Scheff SW, Telling GC. Unaltered prion protein expression in Alzheimer disease patients. Prion 2011; 5:109 - 16; http://dx.doi.org/10.4161/pri.5.2.16355; PMID: 21654203
   PubMed Web of Science ®Google Scholar
• Fukumoto H, Rosene DL, Moss MB, Raju S, Hyman BT, Irizarry MC. Beta-secretase activity increases with aging in human, monkey, and mouse brain. Am J Pathol 2004; 164:719 - 25; http://dx.doi.org/10.1016/S0002-9440(10)63159-8; PMID: 14742275
   PubMed Web of Science ®Google Scholar
• Vassallo N, Herms J. Cellular prion protein function in copper homeostasis and redox signalling at the synapse. J Neurochem 2003; 86:538 - 44; http://dx.doi.org/10.1046/j.1471-4159.2003.01882.x; PMID: 12859667
   PubMed Web of Science ®Google Scholar
• Guillot-Sestier MV, Sunyach C, Druon C, Scarzello S, Checler F. The alpha-secretase-derived N-terminal product of cellular prion, N1, displays neuroprotective function in vitro and in vivo. J Biol Chem 2009; 284:35973 - 86; http://dx.doi.org/10.1074/jbc.M109.051086; PMID: 19850936
   PubMed Web of Science ®Google Scholar
• Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J Neurochem 2006; 97:1634 - 58; http://dx.doi.org/10.1111/j.1471-4159.2006.03907.x; PMID: 16805774
   PubMed Web of Science ®Google Scholar
• Lee HG, Perry G, Moreira PI, Garrett MR, Liu Q, Zhu X, et al. Tau phosphorylation in Alzheimer’s disease: pathogen or protector?. Trends Mol Med 2005; 11:164 - 9; http://dx.doi.org/10.1016/j.molmed.2005.02.008; PMID: 15823754
   PubMed Web of Science ®Google Scholar
• Zhu X, Su B, Wang X, Smith MA, Perry G. Causes of oxidative stress in Alzheimer disease. Cell Mol Life Sci 2007; 64:2202 - 10; http://dx.doi.org/10.1007/s00018-007-7218-4; PMID: 17605000
   PubMed Web of Science ®Google Scholar
• Chung E, Ji Y, Sun Y, Kascsak RJ, Kascsak RB, Mehta PD, et al. Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer’s disease model mouse. BMC Neurosci 2010; 11:130; http://dx.doi.org/10.1186/1471-2202-11-130; PMID: 20946660
   PubMed Web of Science ®Google Scholar
• Freir DB, Nicoll AJ, Klyubin I, Panico S, Mc Donald JM, Risse E, et al. Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites. Nat Commun 2011; 2:336; http://dx.doi.org/10.1038/ncomms1341; PMID: 21654636
   PubMed Web of Science ®Google Scholar
• Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 2009; 457:1128 - 32; http://dx.doi.org/10.1038/nature07761; PMID: 19242475
   PubMed Web of Science ®Google Scholar
• Lesné S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 2006; 440:352 - 7; http://dx.doi.org/10.1038/nature04533; PMID: 16541076
   PubMed Web of Science ®Google Scholar
• Roychaudhuri R, Yang M, Hoshi MM, Teplow DB. Amyloid beta-protein assembly and Alzheimer disease. J Biol Chem 2009; 284:4749 - 53; http://dx.doi.org/10.1074/jbc.R800036200; PMID: 18845536
   PubMed Web of Science ®Google Scholar
• Forloni G, Balducci C. β-amyloid oligomers and prion protein: Fatal attraction?. Prion 2011; 5:10 - 5; http://dx.doi.org/10.4161/pri.5.1.14367; PMID: 21150333
   PubMed Web of Science ®Google Scholar
• Kessels HW, Nguyen LN, Nabavi S, Malinow R. The prion protein as a receptor for amyloid-beta. Nature 2010; 466:E3 - 4, discussion E4-5; http://dx.doi.org/10.1038/nature09217; PMID: 20703260
   PubMed Web of Science ®Google Scholar
• Alier K, Ma L, Yang J, Westaway D, Jhamandas JH. Aβ inhibition of ionic conductance in mouse basal forebrain neurons is dependent upon the cellular prion protein PrPC. J Neurosci 2011; 31:16292 - 7; http://dx.doi.org/10.1523/JNEUROSCI.4367-11.2011; PMID: 22072680
   PubMed Web of Science ®Google Scholar